TherapeuticsMD reported $234K in Gross Profit on Sales for its fiscal quarter ending in June of 2024.





Gross Profit On Sales Change Date
AbbVie USD 10.47B 605M Sep/2025
Cipla INR 41.64B 6.31B Dec/2025
Clal Biotechnology ILS -857K 1.42M Jun/2022
Compugen USD 241K 649K Sep/2025
CSL USD 1.75B 2.53B Jun/2025
Grifols EUR 766.49M 39.74M Dec/2024
Novo Nordisk DKK 64.01B 1.19B Jun/2025
Pfizer USD 3.54B 7.61B Sep/2025
TherapeuticsMD USD 234K 79K Jun/2024